baber/WOPTO huggingface dataset:
Patent DE-69710980-T2 (DE)
Inventor: TERAMOTO YOSHIHIKO
IPC: D01F6/74
Filed: 1997-10-01
Granted: 2003-02-06
Abstract: A polybenzazole fiber characterized by having an elastic modulus of not less than 1350 g/d and requiring not longer than 10 minutes to reduce its water content from 2.0% to 1.5%, when determined using a thermogravimetric analyzer at 110 DEG C after moisture absorption of not less than 2.0% of a fiber, and a method for manufacturing such a polybenzazole fiber, comprising extruding a spinning dope comprising polybenzazole and a polyphosphoric acid from a spinneret to give a dope filament, and cooling the dope filament to not more than 50 DEG C, followed by coagulation and washing. According to the method of the present invention, a polybenzazole fiber showing less decrease in strength by rapid heating can be provided.
Patent DE-69715627-T2 (DE)
Inventor: CARRION ESPELTA JUAN
IPC: E05D15/10
Filed: 1997-03-13
Granted: 2003-06-12
Abstract: The specific object of the suspension mechanism is to ensure, during the fitting and unfitting operations of the door (1), a movement of the door which is perfectly perpendicular to the general closing plane, in order to improve the conditions of said closing operation. This is obtained by fixing the telescopic guide (3) for the sliding of the door (1) to a support (5) from which extend integrally a pair of axis (6) projecting horizontally towards the inside of the carriage (4) or like element and which are conventionally guided by a pair of sheaves (8) and (9) or by any other appropriate means. The longitudinal motion of said axis is synchronized so as to avoid the nodding of the doors or out-of-adjustment of one door with respect to the other when it concerns two complementary doors. <IMAGE>
Patent DE-69720551-T2 (DE)
Inventor: LARTEY A
IPC: A61P1/04
Filed: 1997-04-25
Granted: 2004-02-26
Abstract: Novel macrocyclic 13-membered ring-contracted compounds derived from erythromycins A and B having the Formula (I)    <IMAGE>  (I)  and pharmaceutically acceptable salts thereof, wherein R, R1, R2, R3 and X are specifically defined, having use in treating gastrointestinal disorders associated with hypermotilinemia, pharmaceutical compositions thereof, a method of treating gastrointestinal disorders associated with hypermotilinemia with said pharmaceutical compositions, and processes for the preparation thereof.
Patent DE-69724763-T2 (DE)
Inventor: BEIRENS MARCEL
IPC: F16L5/00
Filed: 1997-12-03
Granted: 2004-07-15
Abstract: PCT No. PCT/FR97/02187 Sec. 371 Date Jul. 17, 1998 Sec. 102(e) Date Jul. 17, 1998 PCT Filed Dec. 3, 1997 PCT Pub. No. WO98/25066 PCT Pub. Date Jun. 11, 1998An interfitting modular metal duct made up of elements forming an inner duct, pairs of elements being united by respective collars, sealing between the two elements being provided by a lip gasket and a fold chamber mounted in the female end of an element and bearing against the outside surface of the corresponding male portion.
Patent DE-69724820-T2 (DE)
Inventor: MIGNARD SAMUEL
IPC: B01J35/10
Filed: 1997-11-07
Granted: 2004-04-08
Abstract: The invention concerns an alumina based catalyst containing, expressed in weight contents of oxides, 2-10 wt.% of cobalt oxide CoO, 10-30 wt.% of molybdenum oxide MoO3 and 4-10 wt.% of phosphorus oxide P2O5, having a BET surface between 100-300 m<2>/g, an ESH compression set higher than 1.4 MPa, an average pore diameter between 8-11 nm, the porous volume of pores of diameter greater than 14 nm is less than 0.08 ml/g, the volume of pores of diameter less than 8 nm not more than 0.05 ml/g,the volume of pores of diameter between 8 and 14 nm is between 0.20 ml/g and 0.8 ml/g. The invention also concerns a hydro-treating method using this catalyst, and in particular of hydrodesulphuration.
Patent DE-69728290-T2 (DE)
Inventor: VAN KOUTRIK ROBERTUS C
IPC: A61K47/38
Filed: 1997-08-14
Granted: 2004-08-05
Abstract: A granulate consisting of a water soluble active ingredient, up to and including 100 wt.% of a cellulose product, such as microcrystalline cellulose and up to and including 0.5 wt.% of a wet granulation binding agent is provided. The granulate is prepared by a wet granulation technique. Compositions based upon the said granulate are disclosed.
Patent DE-69730835-T2 (DE)
Inventor: SCHULZ A
IPC: A61F13/15
Filed: 1997-04-10
Granted: 2005-10-06
Abstract: Skin irritation, such as diaper rash, appearing when the skin is allowed to remain in contact with proteolytic enzymes found in feces is prevented by inactivating the fecal proteolytic enzymes by contact with organophilic clays. The organophilic clays are applied to the skin in areas likely to come into contact with feces or to garments such as diapers. A composition suitable for practicing the method of the invention comprises an amount of an organophilic clay effective to inactivate irritating fecal proteolytic enzymes dispersed in a pharmaceutically acceptable non-toxic dermatological vehicle. A fabric incorporating organophilic clay, preferably dispersed in a matrix of a superabsorbent polymer is useful for preparing diapers for infants that can help to prevent skin irritation by fecal enzymes.
Patent DE-69735404-T2 (DE)
Inventor: VAN MARCKE KAREL CARL
IPC: G01S17/04
Filed: 1997-12-17
Granted: 2006-09-28
Abstract: A proximity detecting device for detecting the presence of an object in a target area. It comprises an emitter (1), a circuitry for supplying electrical pulses thereto, a receiver (3) arranged for receiving the emitted pulses and converting them into electrical signals, an amplifier for amplifying said electrical signals, and a control circuitry for determining on the basis of the amplified electrical signals whether or not the object is present in said target area. According to the invention it further comprises means for determining the amplitude of the amplified electrical signals and means for increasing the energy level of said electrical pulses when the amplitude of the amplified electrical signals is below a first threshold value and for decreasing the energy level of said electrical pulses when the amplitude of the amplified electrical signals is above a second threshold value, which is greater than or equal to said first threshold value. <IMAGE>
Patent DE-69735815-T2 (DE)
Inventor: CAREY G
IPC: H01L27/12
Filed: 1997-03-05
Granted: 2007-04-05
Abstract: A process for formation of thin film transistors (TFTs) on plastic substrates (10) replaces standard thin film transistor fabrication techniques, and uses sufficiently low processing temperatures so that inexpensive plastic substrates may be used in place of standard glass, quartz and silicon wafer-based substrates. The process relies on techniques for depositing semiconductors (20), dielectrics (11, 24) and metals (21, 22, 23) at low temperatures; crystallizing and doping semiconductor layers (20) in the TFT with a pulse energy source; and creating top-gate self-aligned as well as back-gate TFT structures. The process enables the fabrication of amorphous and polycrystalline channel silicon TFTs at temperatures sufficiently low to prevent damage to plastic substrates. The process has use in large area low cost electronics, such as flat panel displays and portable electronics.
Patent DE-69736360-T2 (DE)
Inventor: GOODMAN MARK
IPC: G01N29/36
Filed: 1997-11-14
Granted: 2007-07-19
Abstract: An apparatus for detecting ultrasonic energy generated by a mechanical device and for applying lubricant to the device is presented. The apparatus includes a lubrication tool, such as a grease gun, which has a lubrication delivery element for delivering lubrication to the mechanical device. An ultrasonic transducer is contained in a housing which is removably attached to the outside of the lubrication delivery element such that the transducer makes acoustical contact with the lubrication tool. An electrical circuit, which may be attached to the lubrication device, produces an output signal which indicates the magnitude of detected ultrasonic energy. A method using such an ultrasonic energy detector in conjunction with a lubrication tool to detect the condition of a sealed mechanical rotating device and to determine when sufficient lubricant has been applied is also presented.
Patent DE-69805831-T2 (DE)
Inventor: PATOISEAU JEAN-FRANCOIS
IPC: C07D403/12
Filed: 1998-10-14
Granted: 2003-01-23
Abstract: The invention concerns novel cyclohexane derivatives difunctionalised in 1.4 of general formula (1) in which A represents a group such as (IIa) in which Ar itself represents an aromatic structure such as phenyl or pyrimidinyl optionally substituted by one or several groups such as C1-C3 alkyl, C1-C3 alkoxy, trifluoromethyl or halogen (IIb); B represents a heterocyclic group such as: 3,5-dioxo-(2H,4H)-1,2,4 triazine substituted in position 2 (IIIa); 3-oxo-(2H)-1,2,4 triazine substituted in position 5 (IIIb); 3,5-dioxo-6-amino-(2H,4H)-1,2,4-triazine (IIIc) in which R represents a C1-C3 alkyl group. The invention also concerns the salts of compounds of general formula I with pharmaceutically acceptable acids. It also concerns the various "cis" and "trans" isomers and the various enantiomers with asymmetric carbons.
Patent DE-69809886-T2 (DE)
Inventor: DEBRAS GUY
IPC: C08F4/24
Filed: 1998-02-09
Granted: 2003-07-24
Abstract: A process for producing polyethylene having impact resistance, the process comprising polymerising ethylene, or copolymerising ethylene and an alpha-olefinic comonomer comprising from 3 to 10 carbon atoms, in the presence of a chemically reduced chromium-based catalyst containing in a support thereof from 2 to 3 wt.% of titanium, based on the weight of the catalyst. The invention also provides a chromium-based catalyst for the production of polyethylene by polymerising ethylene or copolymerising ethylene and an alpha-olefinic comonomer comprising from 3 to 10 carbon atoms, the catalyst being chemically reduced and containing in a support from 2 to 3 wt.% of titanium, based on the weight of the catalyst.
Patent DE-69814856-T2 (DE)
Inventor: UVNAES-MOBERG KERSTIN
IPC: A61K38/095
Filed: 1998-03-26
Granted: 2004-05-06
Abstract: The present invention relates to the use of substances with oxytocin activity in order to achieve preference and create acceptance. It also relates to a composition comprising at least one substance with oxytocin activity in order to achieve preference and/or create acceptance. It also relates to a composition containing at least one substance with oxytocin activity and at least one flavouring or fragrance agent in order to create acceptance.
Patent DE-69815100-T2 (DE)
Inventor: BARLOZZARI TERESA
IPC: A61K38/08
Filed: 1998-03-09
Granted: 2004-02-05
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.</PTEXT>
Patent DE-69836384-T2 (DE)
Inventor: KOROPATNICK DONALD JAMES
IPC: C07H21/02
Filed: 1998-09-17
Granted: 2008-02-21
Abstract: Antisene oligonucleotides targeted to sequences in thymidylate synthase (TS) mRNA. In particular the invention relates to antisense oligonucleotides targeted to sequences in the 3' end of TS mRNA, which are both cytostatic on their own when administered to human tumour cell lines, and which also enhance the toxicity of anticancer drugs such as Tomudex. The invention also relates to antisense oligonucleotides targeted to sequences at or near the translation start site at the 5' end of TS mRNA which induce TS gene transcription and enhance cell growth. The invention further relates to a combination product comprising an antisense oligonucleotide in combination with an anticancer agent such as Tomudex (N-(5[N-3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid) or the Zeneca development compound ZD 9331 ((S)-2-(2-fluoro-4-[N-(4-hydroxy-2,7-dimethylquinazolin-6-ylmethyl)-N-(prop-2-ynyl)amino] benzamido-4-(1H-1,2,3,4-tetrazol-5-yl) butyric acid), and to the use of such a combination product in the treatment of cancer.
Patent DE-69838187-T2 (DE)
Inventor: SAGEL PAUL ALBERT
IPC: A61K9/00
Filed: 1998-06-02
Granted: 2008-04-17
Abstract: A system for delivering a tooth whitening substance to a plurality of adjacent teeth, the delivery system comprising a strip of flexible material having a sufficient flexibility to form a curved shape on a plurality of adjacent teeth and a tooth whitening substance. The strip of material is readily conformable to the teeth surfaces and to interstitial tooth spaces without permanent deformation when the delivery system is placed thereagainst. The tooth whitening substance is applied to the strip of material such that when the delivery system is placed on the surface of the teeth, the substance contacts the surface providing an active onto the surface. The substance also provides adhesive attachment between the strip of material and the surface to hold the delivery system in place for a sufficient amount of time to allow the active to act upon the surface. The method of delivery includes pre-coating the strip of material or having the wearer apply substance to the strip of material and then applying the delivery system to the teeth surfaces.
Patent DE-69903412-T2 (DE)
Inventor: WRIGLEY DAVID
IPC: D03D3/04
Filed: 1999-04-09
Granted: 2003-06-18
Abstract: A woven fabric comprises cross-machine direction weft yarns, and an array of interwoven warp yarns, the warp yarns being woven in the machine direction in alternating groups of relatively narrow yarns and relatively wide yarns. The narrow yarns are looped around a respective last weft yarn and backwoven, whilst the wider yarns are extended to form interdigitable loops for engagement of a pintle wire.
Patent DE-69904453-T2 (DE)
Inventor: LEONHARD FRANK ULDALL
IPC: A61B5/0476
Filed: 1999-03-12
Granted: 2003-09-25
Abstract: An input signal (i(t)) having an input frequency-bandwidth is decomposed into a first plurality of signals each representing a distinct, frequency-bandwidth limited portion of the input signal, and for each of the first plurality of signals a signal representing an envelope thereof is provided. The method further comprises, for each signal representing an envelope, providing a second plurality of signals (Oij(t)) each representing a distinct frequency bandwidth-limited portion of the signal representing an envelope. The envelope is preferably provided through rectification and low-pass filtering. The method is useful for analysing a human speech signal for identifying vowels in the speech signal, and for analysing a signal generated by an industrial product. <IMAGE>
Patent DE-69913912-T2 (DE)
Inventor: NODET ALAIN
IPC: F23D14/46
Filed: 1999-10-15
Granted: 2004-11-18
Abstract: The burner (10) is mounted over a hearth plate (20) and fed with gas through an injector (40) fixed to a support (50). The support is fitted from beneath the heart plate and held in place by a nut (60) fitted above it. The nut has a first face (63) which fits against the top of the hearth plate in the assembled position, and a second face (62) which fits against the support, with hard (80) and supple (90) insulating washers between.
Patent DE-69918621-T2 (DE)
Inventor: JUPPO ARI
IPC: D21H17/16
Filed: 1999-08-20
Granted: 2005-08-11
Abstract: The invention relates to a sizing composition usable for the neutral sizing of paper or board, which composition contains a size capable of reacting with cellulose, such as alkyl ketene dimer or alkenyl succinic acid anhydride, and an organic complexing agent. The invention also relates to a process for the manufacture of paper or board.
Patent DE-69921678-T2 (DE)
Inventor: ELYAKOV GEORGY BORISOVICH
IPC: A61P43/00
Filed: 1999-07-21
Granted: 2005-10-20
Abstract: A pharmaceutical composition is provided which comprises an isotonic solution of an 0.02% mixture of di- and trisodim salts of echinochrome (Histochrome). It meets the requirements that apply to injectable formulations. Histochrome administration to human patients normalizes metabolic processes and eliminates inflammation in the retina, vascular membrane and cornea of the eye, improves trophic functions, reduces edema and accelerates epithelization.
Patent DE-69922193-T2 (DE)
Inventor: MEAD H
IPC: G03B31/04
Filed: 1999-05-24
Granted: 2005-11-10
Abstract: In a system and method for dynamically synchronizing a digital soundtrack with a moving picture in motion picture media, the system includes a device for presenting the motion picture media, wherein the motion picture media further includes an analog soundtrack. The digital soundtrack further includes a variable delay to compensate for the distance between a frame in the moving picture and a portion of the digital soundtrack corresponding thereto. A synchronizing device is correlated to a digital soundtrack pickup and an analog soundtrack picture in a feedback loop. A processor in the synchronizing device is adapted to process the digital soundtrack and the analog soundtrack to generate a control signal based on the difference between the location of a transient reference in the analog soundtrack and the same transient in the digital soundtrack, and to use the control system to adjust the variable delay in the digital soundtrack for synchronization thereof.
Patent DE-69925835-T2 (DE)
Inventor: HARMON HERBERT
IPC: B05D1/36
Filed: 1999-04-30
Granted: 2006-05-04
Abstract: The invention provides composite color-plus-clear coatings having improved appearance, especially with respect to wrinkling, and to methods and compositions for providing such coatings. The method of the invention utilizes a second coating composition comprising (A) a film forming component comprising (a) a first component comprising a compound having appended thereto at least one carbamate or urea functional group, or a group convertible to a carbamate or urea group, and (b) a second component comprising a compound reactive with said carbamate or urea groups on component (a), (B) a cyclic anhydride, and (C) a catalyst.
Patent DE-69926754-T2 (DE)
Inventor: MAEAETTAE HANNU
IPC: H01C17/23
Filed: 1999-04-26
Granted: 2006-06-29
Abstract: Surge protector which includes a film pattern (2) formed on a suitable substrate (1) is characterized in that the film pattern (2) essentially consists of narrow lines (2a, 2b, 2c) which extend parallel and adjacent to each other and are electrically in parallel relationship to each other, and bridges (11-24) between the lines. Advantageously, there are three parallel lines. The resistance of the film pattern (2) is trimmed advantageously by cutting (T5, T6, T7, T8, T9, T10) one of the lines (2c) between successive bridges.
Patent HU-E025509-T2 (HU)
Title: A drive unit, preferably an actuator, a control and a construction
Inventor: BASTHOLM JEPPE
IPC: H02M1/15
Filed: 2003-04-16
Abstract: In particular in articles of furniture having at least an element which may be adjusted with a DC motor, preferably via a mechanical transmission, it is desirable to have a level of acoustic noise as low as possible. The power supply to the DC motor is based on a transformer with rectification and smoothing. With the invention it has surprisingly been found that the level of acoustic noise may be reduced significantly in that the secondary side of the transformer has a first control to compensate for the loss in the motor, thereby keeping the speed thereof constant for a long period of time, and a second control adapted to remove the ripple in the voltage, thereby keeping the speed of the motor constant for a short period of time.
Patent HU-E030223-T2 (HU)
Title: A method of producing resistant starch
Inventor: MCCLAIN JAMES A
IPC: C08B30/18
Filed: 2004-02-19
Abstract: This invention relates to the production of resistant starch. Preferably, this invention relates to the production of resistant starch comprising selecting a reaction temperature, acidifying unmodified starch to a pH, wherein the pH is optimum to convert the unmodified starch to resistant starch when at the reaction temperature, heating the acidified unmodified starch to about the reaction temperature, and maintaining the acidified unmodified starch close to about the reaction temperature until the maximum yield of resistant starch has been obtained while maintaining a whiteness level between about 65 and about 100.
Patent HU-E029308-T2 (HU)
Title: Imaging apparatus and methods
Inventor: KIRKBY PAUL ANTHONY
IPC: G02F1/33
Filed: 2007-09-12
Abstract: Methods, systems and apparatus for manipulating electromagnetic radiation such as laser beams. A method and apparatus for correcting magnification chromatic aberration utilises one or more dispersive lenses such that long wavelength components are magnified less than short wavelength components. A telecentric relay is preferred to achieve this aim. Further, the use of polarisers to block the undesired zeroth order components of diffraction emanating from acousto-optic deflectors (AODs) is disclosed. Furthermore, specific designs of AOD including narrow transducer AODs which produce a diverging acoustic wave and AODs having two transducers and a selection switch are disclosed. Further, the invention provides methods, systems and apparatus for allowing the wavelength of radiation to be changed, for providing a user selectable degree of compensation, for providing a scanning and/or a pointing system and for providing a compact system that does not require telecentric relays between adjacent acousto-optic deflectors.
Patent HU-E030186-T2 (HU)
Title: Multistep final filtration of immunoglobulin
Inventor: FALKENSTEIN ROBERTO
IPC: C07K16/32
Filed: 2010-09-29
Abstract: Herein is reported a method for the final filtration of concentrated polypeptide solutions comprising the combination of two immediately consecutive filtration steps with a first filter of 3.0 µm and 0.8 µm pore size and a second filter of 0.45 µm and 0.22 µm pore size.
Patent HU-E034318-T2 (HU)
Title: Methods for evaluating an immune response to a therapeutic agent
Inventor: SUBRAMANYAM MEENA
IPC: G01N33/68
Filed: 2006-04-04
Abstract: The invention relates to methods and products for the identification of a clinically significant immune response in subjects treated with a therapeutic protein. A first aspect of the invention relates to methods and compositions for identifying a clinically significant immune response in patients treated with therapeutic amounts of a VLA4 binding antibody (e.g., natalizumab). A second aspect of the invention concerns the chronological details of sample collection for determining the titre of antibodies against the therapeutic protein, e.g. the collection of at least two samples at two different time points . A third aspect of the invention relates to the selection of the critical threshold level, which corresponds to the antibody titre of untreated patients increased by the double of the standard deviation of this control antibody titre.
Patent TR-200001356-T2 (TR)
Title: Ateşli hastalıkların transjenerik modelleri
Inventor: DUFF GORDON
IPC: C12N15/85
Filed: 1998-11-13
Abstract: Mevcut bulus, bir veya daha fazla sayidaki interlökin genlerin ifadesinin bastirildigi bir memeli sunar. Daha spesifik olarak bulus, hastalikli veya ifadesi tamamen bastirilmis endogenez gene sahip nakavt edilmis insan olmayan bir memeli üretmek için interlökin-1 alici antagonist genin inaktivasyon iptaliyle ilgilidir. Bulus, böyle nakavt edilmis memelilerin hazirlanmasi için yöntemler ve nakavt edilmis memelilerin, interlökin yollarindaki düzensizliklerle iliskilendirilen hastaliklarin veya bozukluklarin tedavi edilmesi için olan tedavisel maddelerin ve rejimlerinin etkililiginin degerlendirilmedi amaciyla kullanilmasi için olan yöntemleri sunar.